Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Pharma Industry to Fight Drug Pricing Criticism With Ad Campaign

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

The drug industry is launching a new ad campaign to push back against the negative media attention over increasing drug prices.  Source: Drug Industry Daily

Continue ReadingPharma Industry to Fight Drug Pricing Criticism With Ad Campaign

Pfizer Reasserts Claims Against Texas for Disclosing Medicaid Rebates to Lawmakers

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

Pfizer is standing firm on its allegations that Texas violated federal laws when it disclosed the company’s Medicaid rebate information to local lawmakers. The company is challenging the state’s argument…

Continue ReadingPfizer Reasserts Claims Against Texas for Disclosing Medicaid Rebates to Lawmakers

Compounding Pharmacy Draws Warning Letter for Misbranded, Unapproved Drugs

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

The FDA Philadelphia district office has issued a warning letter to a compounding pharmacy in Allentown, PA over misbranded drugs and sterility issues. Source: Drug Industry Daily

Continue ReadingCompounding Pharmacy Draws Warning Letter for Misbranded, Unapproved Drugs

UK Looks Toward Investing in Life Sciences Industry

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

British Prime Minister Theresa May is working toward a deal with the UK’s life sciences industry to increase the sector’s productivity and maximize the country’s investment in research and development.…

Continue ReadingUK Looks Toward Investing in Life Sciences Industry

Trump’s Pick to Lead HHS Says He’s Open to Better Ways to Lower Drug Prices

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

Pressed for details by a Senate committee Tuesday, Rep. Tom Price (R-Ga.) — President Donald Trump’s pick to lead HHS — refused to confirm whether or not he would push…

Continue ReadingTrump’s Pick to Lead HHS Says He’s Open to Better Ways to Lower Drug Prices

EMA: 30 Drugs Granted Conditional Market Authorization in the Past Decade

  • Post author:Sam
  • Post published:January 24, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency said 30 drugs across four therapeutic classes have received conditional marketing authorization in the EU since the expedited approval pathway became available a decade ago. Source:…

Continue ReadingEMA: 30 Drugs Granted Conditional Market Authorization in the Past Decade

Trump Freezes FDA Hiring, Temporarily Halts New FDA Regulations

  • Post author:Sam
  • Post published:January 23, 2017
  • Post category:Drug Industry Daily

On the administration’s first full workday yesterday, President Donald Trump froze federal hiring for most agencies, leaving the FDA with about 500 job vacancies out of its workforce of 15,000.…

Continue ReadingTrump Freezes FDA Hiring, Temporarily Halts New FDA Regulations

<b>SHYFT</b> Analytics Appoints <b>Joseph Tyers</b> To Chief Revenue Officer

  • Post author:Sam
  • Post published:January 23, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue Reading<b>SHYFT</b> Analytics Appoints <b>Joseph Tyers</b> To Chief Revenue Officer

Why Celgene Should Consider Buying Rival Biogen

  • Post author:Sam
  • Post published:January 23, 2017
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why Celgene Should Consider Buying Rival Biogen" ALT"Why Celgene Should Consider Buying Rival Biogen"January 24, 2017By Mark Terry, BioSpace.com Breaking News StaffInvestors want <A HREF"http... Source: BioSpace

Continue ReadingWhy Celgene Should Consider Buying Rival Biogen

FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System

  • Post author:Sam
  • Post published:January 23, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingFUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System
  • Go to the previous page
  • 1
  • …
  • 574
  • 575
  • 576
  • 577
  • 578
  • 579
  • 580
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.